{
    "Trade/Device Name(s)": [
        "Xpert GBSTM"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K060540",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022504"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NJR"
    ],
    "Summary Letter Date": "May 17, 2006",
    "Summary Letter Received Date": "May 18, 2006",
    "Submission Date": "February 28, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.3740"
    ],
    "Regulation Name(s)": [
        "Streptococcus spp. serological test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Group B Streptococcus (Streptococcus agalactiae) DNA"
    ],
    "Specimen Type(s)": [
        "Vaginal swab",
        "Rectal swab"
    ],
    "Specimen Container(s)": [
        "Copan Collection and Transport Liquid Stuart Medium",
        "Cepheid GBS Collection Devices"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Automated real-time polymerase chain reaction (PCR)",
        "Fluorogenic target-specific hybridization"
    ],
    "Methodologies": [
        "DNA amplification",
        "Real-time PCR"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert GBS automated real-time PCR assay detecting Group B Streptococcus DNA in vaginal/rectal swabs using the GeneXpert Dx System",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for rapid detection of Group B Streptococcus DNA in vaginal/rectal swabs to identify antepartum and intrapartum colonization, aiding decisions on intrapartum antibiotic prophylaxis",
    "fda_folder": "Microbiology"
}